Association of piperacillin/tazobactam MIC and mortality in a cohort of ceftriaxone-resistant Escherichia coli bloodstream infections treated with piperacillin/tazobactam and carbapenems: a multicentric propensity score-weighted observational cohort study

ConclusionsPiperacillin/tazobactam use might not be associated with increased mortality in treating third-generation cephalosporin-resistantE. coli bloodstream infections when the MIC is<8 mg/L.
Source: Journal of Antimicrobial Chemotherapy - Category: Microbiology Source Type: research